IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7
IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7 million, compared with $28.1 million in the preceding quarter (end Sept. 30) and $29 million for the quarter ending Dec. 31, 2002. VitalWorks had a net loss of $2 million for 4Q 2003, compared with net income of $4.1 million for the corresponding 2002 period. On the bright side, deferred revenues rose to $11.8 million as of Dec. 31 from $7.9 million on Sept. 30. Company executives predicted that PACS will drive growth in radiology IT for the next several years, and that the combination of Amicas' PACS and its own radiology products will provide an advantage in this market.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.